Orbimed Advisors as of March 31, 2025
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 107 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sinovac Biotech SHS | 8.0 | $334M | 2.7M | 122.85 | |
| Edgewise Therapeutics (EWTX) | 7.9 | $331M | 15M | 22.00 | |
| Boston Scientific Corporation (BSX) | 6.8 | $284M | 2.8M | 100.88 | |
| Eli Lilly & Co. (LLY) | 6.6 | $279M | 338k | 825.91 | |
| Enliven Therapeutics (ELVN) | 3.7 | $157M | 8.0M | 19.68 | |
| Intuitive Surgical Com New (ISRG) | 3.4 | $144M | 291k | 495.27 | |
| Stryker Corporation (SYK) | 3.2 | $134M | 359k | 372.25 | |
| Argenx Se Sponsored Adr (ARGX) | 2.9 | $122M | 207k | 591.87 | |
| Edwards Lifesciences (EW) | 2.6 | $111M | 1.5M | 72.48 | |
| Pfizer (PFE) | 2.6 | $110M | 4.4M | 25.34 | |
| UnitedHealth (UNH) | 2.5 | $105M | 201k | 523.75 | |
| Silverback Therapeutics (SPRY) | 2.5 | $104M | 8.3M | 12.58 | |
| Neurocrine Biosciences (NBIX) | 2.5 | $103M | 935k | 110.60 | |
| Alnylam Pharmaceuticals (ALNY) | 2.2 | $94M | 346k | 270.02 | |
| Integer Hldgs (ITGR) | 1.9 | $78M | 663k | 118.01 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.8 | $78M | 160k | 484.82 | |
| Natera (NTRA) | 1.8 | $77M | 547k | 141.41 | |
| Ionis Pharmaceuticals (IONS) | 1.8 | $77M | 2.5M | 30.17 | |
| Disc Medicine (IRON) | 1.7 | $70M | 1.4M | 49.64 | |
| Thermo Fisher Scientific (TMO) | 1.5 | $64M | 129k | 497.60 | |
| Tenet Healthcare Corp Com New (THC) | 1.5 | $63M | 465k | 134.50 | |
| Cytokinetics Com New (CYTK) | 1.4 | $61M | 1.5M | 40.19 | |
| Cg Oncology (CGON) | 1.4 | $61M | 2.5M | 24.49 | |
| Arrivent Biopharma (AVBP) | 1.3 | $56M | 3.0M | 18.49 | |
| Avidity Biosciences Ord (RNA) | 1.3 | $54M | 1.8M | 29.52 | |
| Springworks Therapeutics (SWTX) | 1.2 | $50M | 1.1M | 44.13 | |
| Si-bone (SIBN) | 1.2 | $48M | 3.4M | 14.03 | |
| Axsome Therapeutics (AXSM) | 1.1 | $45M | 387k | 116.63 | |
| Compass Therapeutics (CMPX) | 1.0 | $43M | 22M | 1.90 | |
| Neuropace (NPCE) | 1.0 | $42M | 3.4M | 12.29 | |
| Sionna Therapeutics (SION) | 0.9 | $39M | 3.7M | 10.46 | |
| Upstream Bio (UPB) | 0.8 | $35M | 5.7M | 6.12 | |
| Xtant Med Hldgs Com New (XTNT) | 0.8 | $34M | 73M | 0.47 | |
| Tarsus Pharmaceuticals (TARS) | 0.8 | $34M | 654k | 51.37 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.8 | $34M | 999k | 33.54 | |
| Xenon Pharmaceuticals (XENE) | 0.8 | $32M | 948k | 33.55 | |
| Apellis Pharmaceuticals (APLS) | 0.7 | $31M | 1.4M | 21.87 | |
| Mbx Biosciences (MBX) | 0.7 | $30M | 4.0M | 7.38 | |
| EXACT Sciences Corporation (EXAS) | 0.7 | $29M | 680k | 43.29 | |
| Gilead Sciences (GILD) | 0.5 | $22M | 198k | 112.05 | |
| Corvus Pharmaceuticals (CRVS) | 0.5 | $22M | 6.9M | 3.18 | |
| Terns Pharmaceuticals (TERN) | 0.5 | $21M | 7.6M | 2.76 | |
| Janux Therapeutics (JANX) | 0.5 | $21M | 759k | 27.00 | |
| Rhythm Pharmaceuticals (RYTM) | 0.5 | $20M | 380k | 52.97 | |
| Third Harmonic Bio (THRD) | 0.5 | $20M | 5.8M | 3.47 | |
| Amicus Therapeutics (FOLD) | 0.4 | $19M | 2.3M | 8.16 | |
| Verastem Com New (VSTM) | 0.4 | $17M | 2.9M | 6.03 | |
| Tyra Biosciences (TYRA) | 0.4 | $16M | 1.8M | 9.30 | |
| Rapt Therapeutics | 0.4 | $16M | 13M | 1.22 | |
| Scpharmaceuticals (SCPH) | 0.4 | $16M | 6.1M | 2.63 | |
| Ikena Oncology Nonvoting | 0.4 | $15M | 12M | 1.28 | |
| Vir Biotechnology (VIR) | 0.3 | $15M | 2.2M | 6.48 | |
| Cullinan Oncology (CGEM) | 0.3 | $15M | 1.9M | 7.57 | |
| Immatics SHS (IMTX) | 0.3 | $14M | 3.1M | 4.51 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.3 | $14M | 802k | 17.31 | |
| Amgen (AMGN) | 0.3 | $14M | 44k | 311.55 | |
| Vera Therapeutics Cl A (VERA) | 0.3 | $12M | 481k | 24.02 | |
| C4 Therapeutics Com Stk (CCCC) | 0.3 | $11M | 6.8M | 1.60 | |
| Dyne Therapeutics (DYN) | 0.3 | $11M | 1.0M | 10.46 | |
| Keros Therapeutics (KROS) | 0.2 | $10M | 1.0M | 10.19 | |
| Acelyrin | 0.2 | $9.9M | 4.0M | 2.47 | |
| Agios Pharmaceuticals (AGIO) | 0.2 | $9.5M | 326k | 29.30 | |
| Abcellera Biologics (ABCL) | 0.2 | $9.3M | 4.2M | 2.23 | |
| Adicet Bio (ACET) | 0.2 | $8.6M | 11M | 0.76 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.2 | $8.4M | 6.0M | 1.41 | |
| Prelude Therapeutics (PRLD) | 0.2 | $8.4M | 11M | 0.77 | |
| Spdr Ser Tr S&p Biotech Call Option (XBI) | 0.2 | $8.1M | 100k | 81.10 | |
| Avalo Therapeutics Com New (AVTX) | 0.2 | $7.7M | 967k | 8.01 | |
| Aadi Bioscience (WHWK) | 0.2 | $7.4M | 4.2M | 1.78 | |
| Akero Therapeutics (AKRO) | 0.2 | $7.3M | 180k | 40.48 | |
| Pmv Pharmaceuticals (PMVP) | 0.2 | $7.1M | 6.5M | 1.09 | |
| Trevi Therapeutics (TRVI) | 0.2 | $7.0M | 1.1M | 6.29 | |
| Kestra Med Technologies SHS (KMTS) | 0.1 | $6.2M | 250k | 24.92 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.1 | $6.2M | 1.2M | 5.31 | |
| Inspiremd (NSPR) | 0.1 | $5.7M | 2.1M | 2.69 | |
| Scholar Rock Hldg Corp (SRRK) | 0.1 | $4.9M | 152k | 32.15 | |
| Forte Biosciences Com New (FBRX) | 0.1 | $4.6M | 593k | 7.76 | |
| Ikena Oncology (IKNA) | 0.1 | $4.5M | 3.5M | 1.28 | |
| Krystal Biotech (KRYS) | 0.1 | $4.2M | 24k | 180.30 | |
| Engene Holdings (ENGN) | 0.1 | $4.0M | 892k | 4.48 | |
| Oric Pharmaceuticals (ORIC) | 0.1 | $3.9M | 700k | 5.58 | |
| Bicara Therapeutics (BCAX) | 0.1 | $3.9M | 298k | 13.03 | |
| Q32 Bio (QTTB) | 0.1 | $3.7M | 2.3M | 1.65 | |
| Bioage Labs (BIOA) | 0.1 | $3.5M | 922k | 3.76 | |
| Repare Therapeutics Ord (RPTX) | 0.1 | $3.3M | 3.3M | 0.99 | |
| Passage Bio | 0.1 | $2.5M | 7.0M | 0.35 | |
| Insmed Com Par $.01 (INSM) | 0.1 | $2.2M | 29k | 76.29 | |
| Ceribell (CBLL) | 0.1 | $2.2M | 113k | 19.21 | |
| Instil Bio Com New (TIL) | 0.0 | $2.0M | 117k | 17.36 | |
| Chemomab Therapeutics Sponsored Ads | 0.0 | $1.9M | 1.7M | 1.09 | |
| Cardiff Oncology (CRDF) | 0.0 | $1.8M | 574k | 3.14 | |
| X4 Pharmaceuticals | 0.0 | $1.6M | 6.8M | 0.24 | |
| Nkarta (NKTX) | 0.0 | $1.5M | 821k | 1.84 | |
| Traws Pharma Com New (TRAW) | 0.0 | $1.4M | 606k | 2.30 | |
| Fate Therapeutics (FATE) | 0.0 | $1.3M | 1.7M | 0.79 | |
| Turnstone Biologics Corp (TSBX) | 0.0 | $1.3M | 3.1M | 0.41 | |
| Amylyx Pharmaceuticals (AMLX) | 0.0 | $1.2M | 348k | 3.54 | |
| Biomx Com New (PHGE) | 0.0 | $994k | 1.8M | 0.56 | |
| Kezar Life Sciences Com New (KZR) | 0.0 | $940k | 193k | 4.88 | |
| Tango Therapeutics (TNGX) | 0.0 | $754k | 550k | 1.37 | |
| Adagio Therapeutics (IVVD) | 0.0 | $565k | 934k | 0.61 | |
| Korro Bio (KRRO) | 0.0 | $564k | 32k | 17.41 | |
| Nextcure (NXTC) | 0.0 | $548k | 1.1M | 0.48 | |
| Alto Neuroscience Com Shs (ANRO) | 0.0 | $540k | 250k | 2.16 | |
| Dih Hldg Us Cl A (DHAI) | 0.0 | $443k | 1.9M | 0.23 | |
| Xeris Pharmaceuticals (XERS) | 0.0 | $442k | 80k | 5.49 | |
| Lakeshore Biopharma Ord Shs New (LSBCF) | 0.0 | $344k | 140k | 2.45 |
